Unraveling the Anticancer Potential of SSRIs in Prostate Cancer by Combining Computational Systems Biology and In Vitro Analyses
Open Access
- 8 April 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (15) , 15204-15218
Abstract
Selective serotonin reuptake inhibitors (SSRIs) are known to have anticancer activity against different types of cancer. In this study, an integrative informatics approach was applied to identify compound and genetic perturbations that produce similar effects to SSRIs to formulate systems biology hypotheses and identify biological pathways involved in the putative anticancer effects of SSRIs in prostate cancer. An 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay assessed the antiproliferative effects of SSRIs and drug combinations. Cell death mechanisms were studied using annexin V-FITC/PI staining, and the cell cycle analysis was carried out by counterstaining with propidium iodide. Relative gene expression was assessed using a real-time polymerase chain reaction (PCR). Computational results hypothesized that SSRIs could potentially exert anticancer effects in prostate cancer cell lines by modulating apoptotic and tumorigenesis pathways and significantly inhibiting the growth of prostate cancer cells in a time and concentration-dependent manner. The combination of SSRIs with cisplatin, 5-fluorouracil, and raloxifene resulted in either synergistic or additive effects. SSRIs resulted in a significant increase in the early and late apoptotic activity in PC3 cells. Dapoxetine, paroxetine, and sertraline resulted in cell cycle arrest at the G0/G1 phase. Treatment with either dapoxetine or paroxetine decreases the expression of Bcl-2, CASP8, DR5, and VEGF. At the same time, sertraline decreases the expression of Bcl-2 and VEGF and increases the expression of CASP8 and DR5. Results revealed that SSRIs can potentially act as antiproliferative agents against prostate cancer cells, and their activity is mediated through different signaling pathways.Keywords
Funding Information
- Al-Zaytoonah University of Jordan (2023-2022/17/50)
- Deanship of Academic Research, University of Jordan (2566)
This publication has 58 references indexed in Scilit:
- Novel Drug Candidates for the Treatment of Metastatic Colorectal Cancer through Global Inverse Gene-Expression ProfilingCancer Research, 2014
- Sertraline, an Antidepressant, Induces Apoptosis in Hepatic Cells Through the Mitogen-Activated Protein Kinase PathwayToxicological Sciences, 2013
- Fluoxetine-induced apoptosis in hepatocellular carcinoma cells.2013
- Up-regulation of insulin-like growth factor-binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti-proliferative effect of androgen deprivation therapy combined with 5-FU in human prostate cancer cell linesInternational Journal of Oncology, 2011
- The Expanded Biology of SerotoninAnnual Review of Medicine, 2009
- Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cellsCancer Biology & Therapy, 2008
- Targeting the extrinsic apoptosis pathway in cancerCytokine & Growth Factor Reviews, 2008
- Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stageCell Research, 2007
- Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)Journal of Cellular and Molecular Medicine, 2005
- The in vitro effects of H-89, a specific inhibitor of protein kinase A, in the human colonic carcinoma cell line Caco-2European Journal Of Cancer Prevention, 2003